Perspectives in FTD Research Webinar: AFTD and You – Partners in Drug Development

How does a great scientific idea become an effective treatment? It’s a long and complicated process! Drug development involves many key players, including researchers, companies, regulators, funders, patient advocacy organizations like AFTD and, importantly, community members with lived experience of FTD. The field of FTD has made exciting progress in the past decade, with treatments…

Read More

Statement from The Association for Frontotemporal Degeneration on the Need for Robust and Consistent Medical Research Funding

The Association for Frontotemporal Degeneration (AFTD) continues to urgently advocate for robust and consistent funding for the National Institutes of Health (NIH) in FY 2026 appropriations. Despite being the most common dementia diagnosed in people under 60 years, FTD currently has no effective treatment to prevent its onset and slow its progression. Families and their…

Read More

AFTD Joins Nearly 150 Supporters in Letter Urging Congress to Reject Medicaid and SNAP Cuts

Title Text: AFTD Joins Nearly 150 Supporters in Letter Urging Congress to Reject Medicaid and SNAP Cuts | Background: AFTD logo and Alliance for Aging Research logo

AFTD joined nearly 150 organizations and individuals in a letter penned by the Alliance for Aging Research urging congressional leaders to reject proposed cuts to Medicaid and the Supplemental Nutrition Assistance Program (SNAP). These cuts would have a significant impact on the well-being of families affected by FTD, Alzheimer’s disease, and other dementias, the letter…

Read More